About The Study: Despite decades of guidelines cautioning against their use, many older adults receive potentially inappropriate central nervous system-active medications. Patients with cognitive impairment were more likely than those with normal cognition to receive such medications.
Corresponding Author: To contact the corresponding author, John N. Mafi, MD, MPH, email jmafi@mednet.ucla.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.23697)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.23697?guestAccessKey=af578da3-4974-4e5c-8dd9-27824278476d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011226
JAMA